⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 14, 2013British Journal of PharmacologyOpen Access

Penta‐O‐galloyl‐β‐D‐glucose ameliorates inflammation by inhibiting MyD88/NF‐κB and MyD88/MAPK signalling pathways

Se‐Eun Jang Supriya R. Hyam Jin‐Ju Jeong Myung Joo Han Dong‐Hyun Kim

View Full Paper

Ask AI

Bookmark

Share

Abstract

PGG reduced activation of NF-κB and MAPK signalling pathways by directly interacting with the MyD88 adaptor protein. PGG may ameliorate inflammatory diseases such as colitis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jang et al. (2013) studied this question.

synapsesocial.com/papers/69dc13b8ce788f95bfb64e43 https://doi.org/10.1111/bph.12333

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Checkpoint kinase 1 (Chk1) inhibition promotes motor function recovery through suppressing pyroptosis signalling and attenuating microglial polarization shift to M1 phenotype in spinal cord injury miceBritish Journal of Pharmacology · Thu,
2Saponin extract from Astragalus membranaceus (Fisch.) Bunge regulates gut–brain axis through intestinal Escherichia coli to reduce cerebral oxidative stress to treat vascular dementia in rodentsBritish Journal of Pharmacology · Tue,
3Repurposed catechol‐O‐methyltransferase inhibitors tolcapone and entacapone preferentially suppress aggregation and seeding of P301 mutant tau in human neuronal modelsBritish Journal of Pharmacology · Tue,
4Interaction with NEGR1 affects mGlu 5 cell signalling and the neuroprotection induced by the positive allosteric modulator VU0409551British Journal of Pharmacology · Mon,
5A PTPRO inhibitor Pi mitigates endotoxemia‐induced encephalopathy‐mediated blood–brain barrier disruption through cytoskeletal regulationBritish Journal of Pharmacology · Thu,

More from British Journal of Pharmacology

CRISPR screens identify ACSL4 as a key regulator in macrophage activation and metabolic inflammationFri,
Investigation of the mechanisms and modulation of irinotecan‐induced emesis in Suncus murinusFri,
Highly potent, brain‐penetrant EP 2 receptor antagonists for the treatment of permanent focal cerebral ischaemia in male and female miceTue,
Artificial intelligence (AI)‐enabled RNA therapeutic design: from molecular optimization to system‐level evaluationMon,
Ginsenoside Ra1 alleviates endothelial barrier dysfunction and multi‐organ injury in experimental sepsis via NMMHC IIA inhibitionTue,